Details for Patent: 9,770,406
✉ Email this page to a colleague
Which drugs does patent 9,770,406 protect, and when does it expire?
Patent 9,770,406 protects VEREGEN and is included in one NDA.
This patent has thirty-one patent family members in twenty countries.
Summary for Patent: 9,770,406
Title: | Medicament for the treatment of viral skin and tumour diseases |
Abstract: | The invention relates to a medicament containing a compound of general formula (I), where R.sub.1=independently, a straight or branched, saturated, singly- or multiply-unsaturated, optionally substituted C.sub.11-C.sub.21 alkyl, alkylene or alkinyl group, preferably a C.sub.11-C.sub.15 alkyl, alkylene or alkinyl group, particularly a C.sub.11-C.sub.13 alkyl, alkylene or alkinyl group, most preferably a C.sub.13 alkyl group, R.sub.2=independently, a straight or branched C.sub.1-C.sub.8 alkyl, alkylene or alkinyl group, preferably a C.sub.1-C.sub.6 alkyl, alkylene or alkinyl group, in particular a C.sub.2-C.sub.4 alkyl, alkylene or alkinyl group, most preferably a C.sub.3 alkyl group, a --[CH.sub.2--(CH.sub.2)m-O].sub.nH group with n=1 to 10, preferably n=1 to 5, to m=1 to 5, preferably m=1 to 3, a --CH.sub.2--[CH--(OH)].sub.p[CH.sub.2--R.sub.3]- group, where R.sub.3=independently H or OH, p=1 to 7, preferably p=1 to 4, a pentose group or a hexose group, as therapeutically active agent, alone or in combination with one or several further pharmaceutical agents as a combination preparation for the treatment of viral skin diseases and/or tumor diseases, in particular caused by human papilloma virus (HPV) and/or herpes viruses and a topically acting medicament formulation and the use thereof. |
Inventor(s): | Chang; Yunik (Sonoma, CA), Lathrop; Robert (Fort Collins, CO), Bohm; Erwin (Ladenburg, DE), Gander-Meisterernst; Irene (Stockdorf, DE), Greger; Regina (Iffeldorf, DE), Holldack; Johanna (Aarhus C, DK), Moebius; Ulrich (Gauting-Unterbrunn, DE) |
Assignee: | Medigene AG (Planegg/Martinsried, DE) |
Application Number: | 12/887,250 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,770,406 |
Patent Claim Types: see list of patent claims | Use; Composition; Compound; |
Patent landscape, scope, and claims: | More… ↓ |
Drugs Protected by US Patent 9,770,406
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ani Pharms | VEREGEN | sinecatechins | OINTMENT;TOPICAL | 021902-001 | Oct 31, 2006 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | TREATMENT OF GENITAL WARTS | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,770,406
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Germany | 10156794 | Nov 19, 2001 |
International Family Members for US Patent 9,770,406
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 1448186 | ⤷ Subscribe | 300550 | Netherlands | ⤷ Subscribe |
European Patent Office | 1448186 | ⤷ Subscribe | C01448186/01 | Switzerland | ⤷ Subscribe |
European Patent Office | 1448186 | ⤷ Subscribe | 140 5025-2012 | Slovakia | ⤷ Subscribe |
European Patent Office | 1448186 | ⤷ Subscribe | C300550 | Netherlands | ⤷ Subscribe |
European Patent Office | 1448186 | ⤷ Subscribe | CA 2012 00040 | Denmark | ⤷ Subscribe |
European Patent Office | 1448186 | ⤷ Subscribe | 12C0058 | France | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |